“Alert: Ozempic Label Updated with New Gastrointestinal Side Effect Warning from FDA”
FDA Adds New Gastrointestinal Side Effect Warning to Ozempic Label The Food and Drug Administration (FDA) has recently issued an important update to the label for the diabetes drug, Ozempic (semaglutide), to include a new warning regarding potential gastrointestinal side effects. What is Ozempic? Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist prescribed for the … Read more